folltropin 700 iu powder and solvent for solution for injection
vetoquinol uk limited - porcine follicle stimulating hormone - powder and solvent for solution for injection - 700 international unit(s) - follicle stimulating hormone-pituitary - cattle - hormone
folltropin 700 iu powder and solvent for solution for injection
vetoquinol uk ltd - follicle stimulating hormone (porcine) - powder and solvent for solution for injection - hormone sex - cattle
folltropin-v powder for solution
vetoquinol n a inc - follicle stimulating hormone (fsh) - powder for solution - 400mg - follicle stimulating hormone (fsh) 400mg - cattle
folltropin-v dual pack powder for solution
vetoquinol n a inc - follicle stimulating hormone (fsh) - powder for solution - 400mg - follicle stimulating hormone (fsh) 400mg - cattle
folltropin 700 iu powder and solvent for solution for injection
vetoquinol uk ltd - follicle stimulating hormone (porcine) - powder and solvent for solution for injection - hormone sex - cattle
gonal-f rff pen folltropin alfa injection solution
emd serono, inc. - follitropin (unii: 076whw89tw) (follitropin - unii:076whw89tw) - follitropin 300 [iu] in 0.5 ml
gonal-f follitropin alfa (rch) 900iu /1.5ml (65.52microgram) solution for injection cartridge, pre-assembled in a pen
merck healthcare pty ltd - follitropin alfa, quantity: 600 iu/ml - injection, solution - excipient ingredients: poloxamer; phosphoric acid; sucrose; dibasic sodium phosphate dihydrate; water for injections; methionine; metacresol; sodium hydroxide; monobasic sodium phosphate monohydrate - the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.
gonal-f follitropin alfa (rch) 450iu /0.75ml (32.76microgram) solution for injection cartridge, pre-assembled in a pen
merck healthcare pty ltd - follitropin alfa, quantity: 600 iu/ml - injection, solution - excipient ingredients: methionine; phosphoric acid; dibasic sodium phosphate dihydrate; sodium hydroxide; poloxamer; sucrose; metacresol; water for injections; monobasic sodium phosphate monohydrate - the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.
gonal-f follitropin alfa (rch) 300iu /0.5ml (21.84microgram) solution for injection cartridge, pre-assembled in a pen
merck healthcare pty ltd - follitropin alfa, quantity: 600 iu/ml - injection, solution - excipient ingredients: methionine; phosphoric acid; dibasic sodium phosphate dihydrate; water for injections; sucrose; poloxamer; sodium hydroxide; metacresol; monobasic sodium phosphate monohydrate - the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.
pergoveris follitropin alfa (rch) / lutropin alfa (rch) powder for injection vial with diluent vial
merck healthcare pty ltd - follitropin alfa, quantity: 150 iu; lutropin alfa, quantity: 75 iu - injection, powder for - excipient ingredients: sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate; methionine; polysorbate 20; phosphoric acid; sodium hydroxide - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency.